BioCentury
ARTICLE | Company News

Forma Therapeutics, Cancer Research UK deal

February 1, 2016 8:00 AM UTC

Forma and the not-for-profit’s commercial arm, Cancer Research Technology Ltd., launched a third virtual company and granted it rights to develop compounds against an undisclosed deubiquitinating enzyme (DUB). Forma declined to disclose specific indications that the company will explore and financial details. ...